ARTICLE | Finance
Analyst picks & changes
December 17, 2001 8:00 AM UTC
Neurocrine Biosciences Inc. (NBIX), San Diego, Calif. Business: Neurological, Metabolic UBS Warburg analyst Andrew Gitkin raised his price target to $58 from $50 following NBIX's announcement of posit...